0001209191-18-036048.txt : 20180606
0001209191-18-036048.hdr.sgml : 20180606
20180606161909
ACCESSION NUMBER: 0001209191-18-036048
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180604
FILED AS OF DATE: 20180606
DATE AS OF CHANGE: 20180606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Doogan Declan
CENTRAL INDEX KEY: 0001704234
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38080
FILM NUMBER: 18884007
MAIL ADDRESS:
STREET 1: C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP
STREET 2: 234 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd.
CENTRAL INDEX KEY: 0001689813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 234 CHURCH STREET, SUITE 304
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 234 CHURCH STREET, SUITE 304
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-04
0
0001689813
Biohaven Pharmaceutical Holding Co Ltd.
BHVN
0001704234
Doogan Declan
C/O BIOHAVEN PHARMACEUTICALS
234 CHURCH STREET
NEW HAVEN
CT
06510
1
0
0
0
Common Shares
2018-06-04
4
S
0
39453
35.05
D
1245765
I
By The Declan Doogan 2014 Trust
Common Shares
2018-06-05
4
S
0
49463
35.41
D
1196302
I
By The Declan Doogan 2014 Trust
Common Shares
2018-06-05
4
S
0
300
36.00
D
1196002
I
By The Declan Doogan 2014 Trust
Common Shares
463913
D
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 - $35.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 - $35.98, inclusive.
/s/ Darren K. DeStefano, Attorney-in-fact
2018-06-06